First contingent of AstraZenecas vaccines arrives in Serbia

The first contingent of 150,000 doses of the vaccine against Coronavirus, of the AstraZeneca company, has reached Sunday morning in Serbia. The vaccine plane, which landed at Belgrade Airport “Nicolla Tesla”, has been hosted by Serbian President Aleksandar Vuciq. He has declared that securing these vaccines has been enabled by tripartite talks in [...]
The first contingent of 150,000 doses of the vaccine against Coronavirus, of the AstraZeneca company, has reached Sunday morning in Serbia.
The vaccine plane, which landed at Belgrade Airport “Nicolla Tesla”, has been hosted by Serbian President Aleksandar Vuciq.
He has declared that securing these vaccines has been enabled by trilateral talks between Serbia, Great Britain and India, so representatives of these states in Serbia, Sin McLeod and Vijay Kumar, respectively, have also been seen at the airport.
“Thank you for Serbia's support and for the opportunity to import from India. This moment is of great importance to us,” said Vuciq.
British Ambassador Sin McLeod has said she is happy to see the arrival of the AstraZeneca Company vaccines in this country.
The world's “Vaxing means global work. I expect these vaccines to be available worldwide soon,” is expressed.
Vijay Kumar from India's embassy has said Serbia is the first country in the region to provide these vaccines produced in India.
Indian Prime Minister Narendra Modi has said on several occasions that India will make its production capacities available to other countries,” has declared, among other things, Kumar.
Vuciq has also announced that Serbia is expected to provide other vaccines against Coronavirus, through international mechanization COVAX, late March or early April.
But before the vaccines come from the COVAX program, we're definitely going to vaccinate and recontinate 1.1 million or 1.2 million people. That makes up 20 percent of the adult population “, he said.
After Sunday's shipment, Serbia is considered one of the few countries in the world, where its citizens will be able to choose between four different vaccines against the Coronobrus.
This state has so far provided the American company Pfizer, Russian Sputnik V, Chinese Sinopharm, and now the AstraZeneca company vaccine.
The latter has been approved by the European Union in late January. /rel











